Alimta ® (pemetrexed for injection)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Alimta Summary of Product Characteristics (SmPC)

Alimta (pemetrexed): Use of Other Diluents

The only recommended diluent for reconstitution and further dilution of pemetrexed for IV infusion is 0.9% Sodium Chloride Injection without preservatives.

  • Pemetrexed is physically incompatible with diluents containing calcium, including lactated Ringer’s injection and Ringer’s injection.

  • In the absence of other compatibility studies this medicinal product must not be mixed with other medicinal products.


Alimta EU Summary of Product Characteristics. Utrecht, The Netherlands: Eli Lilly and Company Limited.

Date of Last Review: December 11, 2017

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question